A detailed history of Holderness Investments CO transactions in Novartis Ag stock. As of the latest transaction made, Holderness Investments CO holds 10,614 shares of NVS stock, worth $1.09 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
10,614
Previous 9,828 8.0%
Holding current value
$1.09 Million
Previous $1.05 Million 16.63%
% of portfolio
0.27%
Previous 0.25%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $83,418 - $95,019
786 Added 8.0%
10,614 $1.22 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $62,299 - $72,260
673 Added 7.35%
9,828 $1.05 Million
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $11,908 - $13,558
-125 Reduced 1.35%
9,155 $885,000
Q3 2023

Nov 15, 2023

SELL
$94.73 - $105.13 $2,368 - $2,628
-25 Reduced 0.27%
9,280 $945,000
Q2 2023

Aug 15, 2023

BUY
$92.52 - $104.91 $28,681 - $32,522
310 Added 3.45%
9,305 $938,000
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $13,445 - $15,592
168 Added 1.9%
8,995 $827,000
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $5,666 - $6,939
75 Added 0.86%
8,827 $800,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $11,937 - $13,961
160 Added 1.86%
8,752 $665,000
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $179,479 - $208,968
-2,229 Reduced 20.6%
8,592 $726,000
Q1 2022

May 12, 2022

BUY
$80.11 - $90.62 $34,126 - $38,604
426 Added 4.1%
10,821 $950,000
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $32,119 - $35,516
403 Added 4.03%
10,395 $909,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $27,478 - $31,967
336 Added 3.48%
9,992 $817,000
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $113,369 - $125,219
1,330 Added 15.97%
9,656 $881,000
Q1 2021

May 11, 2021

BUY
$83.5 - $98.47 $1,586 - $1,870
19 Added 0.23%
8,326 $712,000
Q4 2020

Feb 05, 2021

SELL
$78.07 - $94.43 $10,149 - $12,275
-130 Reduced 1.54%
8,307 $784,000
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $255,415 - $287,511
3,156 Added 59.76%
8,437 $737,000
Q1 2020

May 13, 2020

BUY
$70.67 - $99.01 $39,009 - $54,653
552 Added 11.67%
5,281 $435,000
Q3 2019

Nov 01, 2019

SELL
$85.54 - $94.26 $9,580 - $10,557
-112 Reduced 2.31%
4,729 $411,000
Q2 2019

Aug 02, 2019

BUY
$75.4 - $92.8 $2,714 - $3,340
36 Added 0.75%
4,841 $442,000
Q1 2019

May 20, 2019

SELL
$75.32 - $86.15 $6,778 - $7,753
-90 Reduced 1.84%
4,805 $462,000
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $79,331 - $88,335
1,077 Added 28.21%
4,895 $420,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $52,480 - $60,705
784 Added 25.84%
3,818 $329,000
Q2 2018

Aug 16, 2018

BUY
$64.91 - $73.36 $8,438 - $9,536
130 Added 4.48%
3,034 $229,000
Q1 2018

May 10, 2018

SELL
$70.39 - $84.15 $24,636 - $29,452
-350 Reduced 10.76%
2,904 $235,000
Q3 2017

Nov 09, 2017

BUY
$74.14 - $77.27 $241,251 - $251,436
3,254
3,254 $279,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Holderness Investments CO Portfolio

Follow Holderness Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.